Literature DB >> 27468512

Depression, Anxiety, and Quality of Life In Children and Adolescents With Sickle Cell Disease.

J Kelly Graves, Christopher Hodge, Eufemia Jacob.   

Abstract

The relationships among depression, anxiety, and quality of life were tested, as were the effects of age, gender, and pain frequency on these variables in children (n = 44) and adolescents (n = 31) with sickle cell disease. Participants completed the Revised Child Anxiety and Depression Scale (ROADS) and the Pediatric Quality of Life (PedQL Generic Model). The mean and standard deviation for summary RCADS scores for the majority of participants were below the clinical thresholds of T < 65, indicating low risk for depression (n = 65; 89.3%) and anxiety (n = 70; 93.3%). The subscale scores for the different dimensions of QOL health were a) psychosocial (73.3 ± 15.9), b) emotional (75.0 ± 20.7), c) social (80.8 ± 19.1), d) school functioning (64.0 ≥ 19.8), and e) physical (77.4 ± 17.4). Significant negative correlations were found between mean total quality of life scores and symptoms of a) general anxiety (r = -0.51, p < 0.0001), b) depression (r = -0.66, p < 0.0001), c) obsessive compulsive (r = -0.53, p < 0.0001), d) panic (r = -0.60, p < 0.0001), and e) social phobia (r = -0.57, p < 0.0001). Age and gender did not have significant effects on risk for depression and anxiety or poor QOL. Pain frequency also did not have significant effects on the risk for depression and anxiety. Findings suggest that health care providers need to screen for anxiety and depression, and make referrals for early interventions to improve quality of life and promote school function in youth with sickle cell disease.

Entities:  

Mesh:

Year:  2016        PMID: 27468512

Source DB:  PubMed          Journal:  Pediatr Nurs        ISSN: 0097-9805


  18 in total

1.  Psychosocial Predictors of Acute and Chronic Pain in Adolescents Undergoing Major Musculoskeletal Surgery.

Authors:  Jennifer A Rabbitts; Tonya M Palermo; Chuan Zhou; Alagumeena Meyyappan; Lucas Chen
Journal:  J Pain       Date:  2020-06-15       Impact factor: 5.820

2.  Impact of hereditary pancreatitis on patients and their families.

Authors:  Celeste A Shelton; Robin E Grubs; Chandraprakash Umapathy; Dhiraj Yadav; David C Whitcomb
Journal:  J Genet Couns       Date:  2020-02-05       Impact factor: 2.537

3.  Parent pain catastrophizing predicts child depressive symptoms in youth with sickle cell disease.

Authors:  Alana Goldstein-Leever; Lindsey L Cohen; Carlton Dampier; Soumitri Sil
Journal:  Pediatr Blood Cancer       Date:  2018-03-07       Impact factor: 3.167

4.  Depression, quality of life, and medical resource utilization in sickle cell disease.

Authors:  Soheir S Adam; Charlene M Flahiff; Shital Kamble; Marilyn J Telen; Shelby D Reed; Laura M De Castro
Journal:  Blood Adv       Date:  2017-10-12

5.  Performance of ICD-10-CM diagnosis codes for identifying children with Sickle Cell Anemia.

Authors:  Sarah L Reeves; Brian Madden; Meng Wu; Lauren S Miller; David Anders; Michele Caggana; Lindsay W Cogan; Mary Kleyn; Isabel Hurden; Gary L Freed; Kevin J Dombkowski
Journal:  Health Serv Res       Date:  2020-01-09       Impact factor: 3.402

6.  Systematic Review: Pain and Emotional Functioning in Pediatric Sickle Cell Disease.

Authors:  Steven K Reader; Laura M Rockman; Katherine M Okonak; Nicole M Ruppe; Colleen N Keeler; Anne E Kazak
Journal:  J Clin Psychol Med Settings       Date:  2020-06

7.  Quality of Life of Latino and Non-Latino Youth With Sickle Cell Disease as Reported by Parents and Youth.

Authors:  Jennel C Osborne; Nancy S Green; Arlene M Smaldone
Journal:  Hisp Health Care Int       Date:  2020-03-03

8.  Child, Parent, and Family Adjustment for Patients Followed in a Multidisciplinary Spina Bifida Clinic.

Authors:  Tess S Simpson; Leah A Grande; Jessica J Kenny; Pamela E Wilson; Robin L Peterson
Journal:  Top Spinal Cord Inj Rehabil       Date:  2022-08-17

Review 9.  Considerations for Selecting Cognitive Endpoints and Psychological Patient-Reported Outcomes for Clinical Trials in Pediatric Patients With Sickle Cell Disease.

Authors:  Anna M Hood; Lori E Crosby; Hanne Stotesbury; Melanie Kölbel; Fenella J Kirkham
Journal:  Front Neurol       Date:  2022-06-21       Impact factor: 4.086

10.  Psychosocial and Clinical Risk Factors Associated with Substance Use in Observational Cohort of Patients with Sickle Cell Disease.

Authors:  J Deanna Wilson; Sophie Lanzkron; Lydia H Pecker; Shawn M Bediako; Dingfen Han; Mary Catherine Beach
Journal:  Subst Use Misuse       Date:  2020-08-07       Impact factor: 2.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.